Literature DB >> 17910027

Control of beta globin genes.

Milind C Mahajan1, Subhradip Karmakar, Sherman M Weissman.   

Abstract

The developmental changes in expression of the beta like genes from embryonic to adult stages of human life are controlled at least partially at the level of the promoter sequences of these genes and their binding factors, and competition for promoter specific interactions with the locus control region (LCR). In recent years, the control of beta globin genes has also been investigated at the level of chromatin structure involving the chemical modification of histones and their remodelling by DNA dependent ATPases (SMARCA) containing protein complexes. The role of intergenic RNA is also being investigated with renewed interest. Although a wealth of information on the structure/function relationship of the LCR and globin promoters has been gathered over more than two decades, the fundamental nature of the control of these genes at the molecular level is still not completely understood. In the following pages, we intend to briefly describe the progress made in the field and discuss future directions. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17910027     DOI: 10.1002/jcb.21507

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  21 in total

1.  Transcriptional environment and chromatin architecture interplay dictates globin expression patterns of heterospecific hybrids derived from undifferentiated human embryonic stem cells or from their erythroid progeny.

Authors:  Kai-Hsin Chang; Andy Huang; Hemei Han; Yi Jiang; Xiangdong Fang; Chao-Zhong Song; Steve Padilla; Hao Wang; Hongzhu Qu; John Stamatoyannopoulos; Qiliang Li; Thalia Papayannopoulou
Journal:  Exp Hematol       Date:  2013-08-28       Impact factor: 3.084

2.  Acetylation of EKLF is essential for epigenetic modification and transcriptional activation of the beta-globin locus.

Authors:  Tanushri Sengupta; Ken Chen; Eric Milot; James J Bieker
Journal:  Mol Cell Biol       Date:  2008-08-18       Impact factor: 4.272

Review 3.  Hemoglobin research and the origins of molecular medicine.

Authors:  Alan N Schechter
Journal:  Blood       Date:  2008-11-15       Impact factor: 22.113

4.  Prevention of transcriptional silencing by a replicator-binding complex consisting of SWI/SNF, MeCP1, and hnRNP C1/C2.

Authors:  Liang Huang; Haiqing Fu; Chii Mei Lin; Amy L Conner; Ya Zhang; Mirit I Aladjem
Journal:  Mol Cell Biol       Date:  2011-06-20       Impact factor: 4.272

5.  Temporal changes in gene expression in the skin of patients treated with isotretinoin provide insight into its mechanism of action.

Authors:  Amanda M Nelson; Wei Zhao; Kathryn L Gilliland; Andrea L Zaenglein; Wenlei Liu; Diane M Thiboutot
Journal:  Dermatoendocrinol       Date:  2009-05

6.  Transcriptional enhancers in animal development and evolution.

Authors:  Mike Levine
Journal:  Curr Biol       Date:  2010-09-14       Impact factor: 10.834

7.  Dynamics of alpha-globin locus chromatin structure and gene expression during erythroid differentiation of human CD34(+) cells in culture.

Authors:  Milind C Mahajan; Subhradip Karmakar; Peter E Newburger; Diane S Krause; Sherman M Weissman
Journal:  Exp Hematol       Date:  2009-07-14       Impact factor: 3.084

Review 8.  Analysis of epigenetic alterations to chromatin during development.

Authors:  Meghan E Minard; Abhinav K Jain; Michelle Craig Barton
Journal:  Genesis       Date:  2009-08       Impact factor: 2.487

9.  Regulation of protocadherin gene expression by multiple neuron-restrictive silencer elements scattered in the gene cluster.

Authors:  Yuen-Peng Tan; Shaobing Li; Xiao-Juan Jiang; Wailin Loh; Yik Khon Foo; Chay-Boon Loh; Qiurong Xu; Wai-Hong Yuen; Michael Jones; Jianlin Fu; Byrappa Venkatesh; Wei-Ping Yu
Journal:  Nucleic Acids Res       Date:  2010-04-12       Impact factor: 16.971

10.  cJun modulates Ggamma-globin gene expression via an upstream cAMP response element.

Authors:  Sirisha Kodeboyina; Parimaladevi Balamurugan; Li Liu; Betty S Pace
Journal:  Blood Cells Mol Dis       Date:  2009-10-27       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.